Abrogation of TNFα Production During Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12
PLoS ONE - United States
doi 10.1371/journal.pone.0090116
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 28, 2014
Authors
Publisher
Public Library of Science (PLoS)